BKV (NYSE:BKV - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Friday, May 9th. Analysts expect BKV to post earnings of $0.05 per share and revenue of $223.20 million for the quarter.
BKV (NYSE:BKV - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.01 earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.11. The business had revenue of $119.78 million for the quarter, compared to the consensus estimate of $183.77 million. On average, analysts expect BKV to post $-2 EPS for the current fiscal year and $1 EPS for the next fiscal year.
BKV Price Performance
Shares of BKV opened at $18.10 on Friday. The business's 50 day moving average price is $18.99 and its 200-day moving average price is $21.08. BKV has a 52 week low of $15.00 and a 52 week high of $26.78.
Insider Activity
In other news, CFO David Tameron sold 5,000 shares of the company's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $20.03, for a total transaction of $100,150.00. Following the completion of the sale, the chief financial officer now owns 47,779 shares of the company's stock, valued at $957,013.37. This represents a 9.47 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ethan Ngo sold 21,667 shares of the stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $20.09, for a total transaction of $435,290.03. Following the completion of the transaction, the insider now owns 286,008 shares in the company, valued at $5,745,900.72. This trade represents a 7.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 41,667 shares of company stock valued at $851,490 over the last three months.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on BKV shares. KeyCorp cut their target price on BKV from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 4th. Barclays dropped their target price on shares of BKV from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Finally, Truist Financial reduced their price target on shares of BKV from $31.00 to $30.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $27.75.
Get Our Latest Stock Analysis on BKV
About BKV
(
Get Free Report)
BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.